Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Practice Variation in IgA Nephropathy: When the Field Evolves Faster Than Consensus.
Journal: Kidney360
Published: August 27, 2026
Beyond Genotype: Multidomain Biomarker-Integrated Risk Scores Reveal Prognostic phenotypes Among Individuals with High-Risk APOL1 Genotypes.
Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026
Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights From a Phase 2 Trial of TRPC6 Inhibition.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: April 18, 2026
One Year at AJKD: A Perspective From the 2023-2024 Editorial Interns.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: September 10, 2024
Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV-2 Infection.
Journal: Kidney360
Published: June 18, 2024
Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV2 Infection.
Journal: medRxiv : the preprint server for health sciences
Published: November 14, 2023
Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options.
Journal: Kidney international reports
Published: August 05, 2023
Urinary Biomarkers of Kidney Tubule Health and Mortality in Persons with CKD and Diabetes Mellitus.
Journal: Kidney360
Published: April 28, 2023
Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing Outcomes.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: September 20, 2022
Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
Journal: JACC. Basic to translational science
Published: June 06, 2022
Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study.
Journal: Journal of cardiothoracic surgery
Published: March 20, 2022
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: February 21, 2022
Last Updated: 09/26/2026